Wound Infection: Clinical Trials

15 trials for Wound Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed. 15 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 115Completed 15
Phase 25Completed 5

Follow Wound Infection: new trials by email Literature Review of Wound Infection trials Research Report on Wound Infection

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Red Light Photobiomodulation and Topical Disinfectants
Methylene Blue Only, Chlorhexidine Gluconate Only, Methylene Blue + Chlorhexidine Gluconate - Healthcare Associated Infection, Nosocomial Infection
Phase 1 / Phase 2CompletedOndine Biomedical Inc.282023-01-102023-04-04
Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis
Tebipenem Pivoxil Hydrobromide - Diabetes, Wound Infection
Phase 1CompletedHartford Hospital122021-07-012023-10-23
Chlorhexidine Vaginal Preparation for Reduction of Post-cesarean Endometritis and Sepsis
Chlorhexidine Gluconate vaginal solution 0.05% - Postpartum Endometritis, Wound Infection
Phase 1 / Phase 2CompletedZagazig University8402020-05-152022-09-23
Omadacycline Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis
Omadacycline, Microdialysis Catheter Insertion - Diabetes, Wound Infection
Phase 1CompletedHartford Hospital142020-02-102021-08-25
Pharmacokinetic Study of Vancomycin, Clindamycin And/or Gentamicin Administration During Surgery Using a Microdialysis Procedure
Blood and microdialysis samples - Surgical Site Infection
Phase 1CompletedPoitiers University Hospital252019-05-262025-01-16
Prophylactic Antibiotics After Cesarean
Cephalexin, Placebo, Metronidazole - Surgical Site Infection
Phase 1CompletedThe University of Texas Medical Branch, Galveston3212017-08-012023-08-16
Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis
Tedizolid, Microdialysis Catheter Insertion - Diabetes, Wound Infection
Phase 1CompletedHartford Hospital182016-02-232019-01-15
Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections
Ceftolozane/tazobactam, Microdialysis Catheter Insertion - Diabetes, Wound Infection
Phase 1CompletedHartford Hospital162016-02-192019-01-15
Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA
Chloraprep, 0.9% Physiological Saline, ZuraPrep without IPA - Surgical Site Infection
Phase 1CompletedZurex Pharma, Inc.2082014-07-012015-03-17
Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA
ChloraPrep, 0.1% Sodium Lauryl Sulfate, 0.9% Physiological Saline - Surgical Site Infection
Phase 1CompletedZurex Pharma, Inc.402014-06-012014-10-27
DFA-02 in Patients Undergoing Colorectal Surgery
DFA-02, Placebo - Surgical Site Infection
Phase 1 / Phase 2CompletedDr. Reddy's Laboratories Limited302012-02-012014-09-01
Tumescent Antibiotic Delivery Pharmacokinetics
Tumescent Antibiotic Delivery of cefazolin with or without metronidazole, Intravenous Antibiotic Delivery - Prevention of Surgical Site Infections
Phase 1CompletedKlein, Jeffrey A., M.D.42009-03-012011-09-28
A Comparison Of The 3M TM S Surgical Skin Closure System To The Standard Vicryl Suture Closure of Sternotomy Incisions During Cardiac Surgery
Vicryl Suture, 3M TM S Surgical Skin Closure System - Wound Infection
Phase 1CompletedAmerican Heart Association362007-09-012012-07-18
Study of the Efficacy of Plain Soap and Water Versus Alcohol-based Rubs for Surgical Hand Preparation
Plain soap and water (PSW), Alcohol-based hand rub (ABHR) - Postoperative Wound Infection
Phase 1 / Phase 2CompletedUniversity Hospital, Geneva33172007-01-012012-08-21
StrataGraft™ Skin Tissue (Human Donor Skin) In The Surgical Management Of Complex Skin Defects
StrataGraft Skin Tissue, Cadaver allograft - Third Degree Burn, Burns
Phase 1 / Phase 2CompletedStratatech, a Mallinckrodt Company152006-07-012019-10-16

Narrower conditions

Surgical Wound Infection (8)  ·  Diabetes Mellitus (4)  ·  Burns (1)  ·  Cross Infection (1)  ·  Degloving Injuries (1)

Broader conditions

Infections (15)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Postoperative Complications (8)  ·  Endocrine System Diseases (4)  ·  Glucose Metabolism Disorders (4)  ·  Metabolic Diseases (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Disease Attributes (1)  ·  Iatrogenic Disease (1)  ·  Soft Tissue Injuries (1)  ·  Wounds and Injuries (1)

Interventions

Ethanol (2)  ·  Metronidazole (2)  ·  chlorhexidine gluconate (2)  ·  citrate, isopropyl alcohol, methylene blue, parabens drug combination (2)  ·  2-Propanol (1)  ·  Blood Specimen Collection (1)  ·  Cefazolin (1)  ·  Cephalexin (1)  ·  Sodium Dodecyl Sulfate (1)  ·  Water (1)  ·  ceftolozane, tazobactam drug combination (1)  ·  omadacycline (1)  ·  tedizolid (1)  ·  tedizolid phosphate (1)

Sponsors

Hartford Hospital (4)  ·  Zurex Pharma, Inc. (2)  ·  American Heart Association (1)  ·  Dr. Reddy's Laboratories Limited (1)  ·  Klein, Jeffrey A., M.D. (1)  ·  Ondine Biomedical Inc. (1)  ·  Poitiers University Hospital (1)  ·  Stratatech, a Mallinckrodt Company (1)  ·  The University of Texas Medical Branch, Galveston (1)  ·  University Hospital, Geneva (1)  ·  Zagazig University (1)

Countries

United States (12)  ·  France (1)  ·  Kenya (1)  ·  Saudi Arabia (1)

Top investigators

David P Nicolau, PharmD (3)  ·  Ahmed Shafiek (1)  ·  Antonio F Saad, MD (1)  ·  Esther Campbell (1)  ·  Harold L Lazar MD (1)  ·  Hytham Atia (1)  ·  Kent Allenby, MD (1)  ·  Maggie Butler, PhD (1)  ·  Peter M Nthumba, MD (1)  ·  Tomefa E Asempa, PharmD (1)

Results publications

PMID 19276766, PMID 20878941, PMID 21475006, PMID 21554389, PMID 22297835, PMID 27313846, PMID 28893779, PMID 40403315

NIH funding

R44AR047499 (1)